SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial

Por: Balmana, J, Pascual, T, Llop-Guevara, A, Tolosa, P, Lopez-Barajas, IB, Lopez, MEP, Adamo, B, Teruel-Garcia, I, Ponce, J, Gonzalez-Cordero, M, Villaro, GV, Roso, LL, Bofill, FJS, Martinez, MTM, Guerrero, ANE, Prat, A and Elizalde, VS

---

Publicada: 1 may 2022 Ahead of Print: 1 may 2022

---

---

Filiaciones:
Balmana, J:
 Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain

Pascual, T:
 Hosp Clin Barcelona, SOLTI Canc Res Grp, Clin Res Dept, Barcelona, Spain

Llop-Guevara, A:
 Vall dHebron Inst Oncol VHIO, Cellex Ctr, Barcelona, Spain

Tolosa, P:
 Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

Lopez-Barajas, IB:
 Hosp Clin San Cecilio, Oncol Dept, Granada, Spain

Lopez, MEP:
 CHUAC Complexo Hosp Univ A Coruna, Oncol, La Coruna, Spain

Adamo, B:
 Hosp Clin Barcelona, Breast Canc Dept, Barcelona, Spain

:
 Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Med Oncol, Badalona, Spain

Ponce, J:
 Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain

Gonzalez-Cordero, M:
 Hosp Univ Badajoz, Hosp Infanta Cristina, Med Oncol Dept, Badajoz, Spain

Villaro, GV:
 Hosp Univ Josep Trueta, Catalan Inst Oncol ICO, Med Oncol, Girona, Spain

Roso, LL:
 Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

Bofill, FJS:
 Hosp Univ Virgen Valme, Med Oncol Dept, Seville, Spain

Martinez, MTM:
 Hosp Clin Univ Valencia, Oncol Dept, Valencia, Spain

Guerrero, ANE:
 SOLTI Canc Res Grp, Sci, Barcelona, Spain

Prat, A:
 Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain

Elizalde, VS:
 Vall dHebron Inst Oncol VHIO Cellex Ctr, Expt Therapeut Grp Dept, Barcelona, Spain